David Metcalfe - Nextgen Healthcare Executive Vice President CTO
| NXGNDelisted Stock | USD 16.53 0.05 0.30% |
President
Mr. David A. Metcalfe is Executive Vice President, Chief Technology Officer of the Company. Prior to joining the Company, Mr. Metcalfe served as Vice President of RD at Becton, Dickinson Company, a leading worldwide medical technology company, from March 2015 to January 2016. Previously, Mr. Metcalfe was Vice President of Product Development at CareFusion Corporationration, a global medical technology company servicing the critical care market, from September 2012 to March 2015, at which time CareFusion was acquired by Becton, Dickinson Company. From 2008 to 2012, Mr. Metcalfe was Vice President of Development for Allscripts Healthcare Solutions, a provider of healthcare information technology solutions. Earlier in his career, Mr. Metcalfe held numerous other seniorlevel development positions at technology companies since 2016.
| Age | 60 |
| Tenure | 8 years |
| Phone | 404 467 1500 |
| Web | https://www.nextgen.com |
Nextgen Healthcare Management Efficiency
The company has return on total asset (ROA) of 0.038 % which means that it generated a profit of $0.038 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0144) %, meaning that it created substantial loss on money invested by shareholders. Nextgen Healthcare's management efficiency ratios could be used to measure how well Nextgen Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.Nextgen Healthcare currently holds 274.76 M in liabilities with Debt to Equity (D/E) ratio of 0.03, which may suggest the company is not taking enough advantage from borrowing. Nextgen Healthcare has a current ratio of 1.26, suggesting that it may not be capable to disburse its financial obligations when due. Note, when we think about Nextgen Healthcare's use of debt, we should always consider it together with its cash and equity.
NextGen Healthcare, Inc. provides healthcare technology solutions in the United States. NextGen Healthcare, Inc. was incorporated in 1974 and is headquartered in Atlanta, Georgia. Nextgen Healthcare operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 2655 people. Nextgen Healthcare (NXGN) is traded on NASDAQ Exchange in USA and employs 2,783 people. Management Performance
| Return On Equity | -0.0144 | |||
| Return On Asset | 0.038 |
Nextgen Healthcare Leadership Team
Elected by the shareholders, the Nextgen Healthcare's board of directors comprises two types of representatives: Nextgen Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nextgen. The board's role is to monitor Nextgen Healthcare's management team and ensure that shareholders' interests are well served. Nextgen Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nextgen Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Srinivas Velamoor, Chief VP | ||
| David Metcalfe, Executive Vice President CTO | ||
| David Ahmadzai, Corp VP | ||
| David Slazyk, Chief Officer | ||
| Colleen Edwards, VP Marketing | ||
| Mitchell Waters, Ex Growth | ||
| David Sides, Pres CEO | ||
| James Arnold, CFO, Executive Vice President | ||
| Jeffrey Linton, Executive Vice President General Counsel, Secretary | ||
| Matthew Scalo, VP Relations |
Nextgen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Nextgen Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0144 | |||
| Return On Asset | 0.038 | |||
| Profit Margin | (0.01) % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 1.68 B | |||
| Shares Outstanding | 67.1 M | |||
| Shares Owned By Insiders | 33.55 % | |||
| Shares Owned By Institutions | 81.43 % | |||
| Number Of Shares Shorted | 4.84 M | |||
| Price To Earning | 253.66 X |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Nextgen Stock
If you are still planning to invest in Nextgen Healthcare check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nextgen Healthcare's history and understand the potential risks before investing.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Commodity Directory Find actively traded commodities issued by global exchanges |